Detailed information for compound 424060
Basic information
Technical information
- Name: Unnamed compound
- MW: 544.409 | Formula: C24H40Br2N4
-
H donors: 2
H acceptors: 0
LogP: 8.19
Rotable bonds: 15
Rule of 5 violations (Lipinski): 2 - SMILES: CNc1cc[n+](cc1)CCCCCCCCCCCC[n+]1ccc(cc1)NC.[Br-].[Br-]
- InChi: 1S/C24H38N4.2BrH/c1-25-23-13-19-27(20-14-23)17-11-9-7-5-3-4-6-8-10-12-18-28-21-15-24(26-2)16-22-28;;/h13-16,19-22H,3-12,17-18H2,1-2H3;2*1H
- InChiKey: RNVZPYUPUSLPDF-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
No curated genes were found associated with this compound
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0356 | 0.011 | 0.0058 |
| Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0328 | 0.0096 | 0.0096 |
| Loa Loa (eye worm) | STAT protein | 0.0312 | 0.0088 | 0.0012 |
| Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0289 | 0.0076 | 0.0076 |
| Loa Loa (eye worm) | hypothetical protein | 0.0356 | 0.011 | 0.0034 |
| Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 1.9682 | 1 | 1 |
| Toxoplasma gondii | 1,3-beta-glucan synthase component protein | 0.1296 | 0.0591 | 0.5 |
| Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 1.9682 | 1 | 1 |
| Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 1.9682 | 1 | 1 |
| Brugia malayi | STAT protein, DNA binding domain containing protein | 0.0312 | 0.0088 | 0.0088 |
| Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0262 | 0.0062 | 0.0062 |
| Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0356 | 0.011 | 0.0058 |
| Loa Loa (eye worm) | hypothetical protein | 1.9682 | 1 | 1 |
| Schistosoma mansoni | metabotropic glutamate receptor | 0.0242 | 0.0052 | 0.0052 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Activity (ADMET) | 0 | Cytotoxicity against human erythrocytes assessed as hemolytic activity at 500 uM | ChEMBL. | 17383187 |
| MIC (functional) | = 44 % | Antifungal activity against Aspergillus funigatus ATCC 204 305 | ChEMBL. | 17383187 |
| MIC (functional) | = 1.4 uM | Antifungal activity against Candida albicans ATCC 10231 | ChEMBL. | 17383187 |
| MIC (functional) | = 1.4 uM | Antifungal activity against Candida albicans ATCC 10231 | ChEMBL. | 17383187 |
| MIC (functional) | = 2.8 uM | Antifungal activity against Cryptococcus neoformans ATCC 90112 | ChEMBL. | 17383187 |
| MIC (functional) | = 2.8 uM | Antifungal activity against Scedosporium prolificans 1-003-040 | ChEMBL. | 17383187 |
| MIC (functional) | = 2.8 uM | Antifungal activity against Scedosporium apiospermum 1-003-056 | ChEMBL. | 17383187 |
| MIC (functional) | = 2.8 uM | Antifungal activity against Cryptococcus neoformans ATCC 90112 | ChEMBL. | 17383187 |
| MIC (functional) | = 11 uM | Antifungal activity against Aspergillus terreus 03-232-378 | ChEMBL. | 17383187 |
| MIC (functional) | = 44 uM | Antifungal activity against Aspergillus flavus ATCC 204 304 | ChEMBL. | 17383187 |
| MIC (functional) | = 44 uM | Antifungal activity against Fusarium solani 04-132-4207 | ChEMBL. | 17383187 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL227950
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.